Basic Information
| RNALocate ID: | RLID:01001596 |
| RNA Symbol: | hsa-miR-7-5p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-7 |
| RNA ID: | miRBase:MIMAT0000252 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22984580 |
| Tissue/Cell Line: | Cell line (HEK-293|HeLa) |
| Method: | Next-generation RNA sequencing |
| Description: | The differential association of miRNA to mitochondria of both HEK293 and HeLa has been summarized in Table S3. Data are collected from Table S3: Pattern of miRNAs associated with mitochondria of HEK293 and HeLa. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001595 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001597 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11001363 | Exosome | Human cervical carcinoma cell line (HeLa|SiHa) | 25760330 |
| RLID:11001364 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001365 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001366 | Exosome | Brain tissue | 23382797 |
| RLID:11001367 | Exosome | Serum | 24683445 |
| RLID:11001368 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11001369 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:21000261 | Cell body | HEK-293 cells|HeLa cells | 23446346 |
| RLID-D:11000045 | Exosome | Chronic lymphocytic leukemia cells|Colon tissue|Epithelial cells|Tongue tissue | |
| RLID-D:11000314 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-7-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-68783 |
| MNDR | hsa-miR-7-5p | Tongue squamous cell carcinoma | MNDR-E-MI-68784 |
| MNDR | hsa-miR-7-5p | Oral squamous cell carcinoma | MNDR-E-MI-68785 |
| MNDR | hsa-miR-7-5p | Large cell neuroendocrine cancer | MNDR-E-MI-68786 |
| MNDR | hsa-miR-7-5p | Medulloblastoma | MNDR-E-MI-68787 |
| MNDR | hsa-miR-7-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-68788 |
| MNDR | hsa-miR-7-5p | Ovarian serous carcinoma | MNDR-E-MI-68789 |
| MNDR | hsa-miR-7-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-68790 |
| MNDR | hsa-miR-7-5p | Autism spectrum disorder | MNDR-E-MI-68791 |
| MNDR | hsa-miR-7-5p | Lymphoma | MNDR-E-MI-68792 |
| MNDR | hsa-miR-7-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-68793 |
| MNDR | hsa-miR-7-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-68794 |
| MNDR | hsa-miR-7-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-68795 |
| MNDR | hsa-miR-7-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-68796 |
| MNDR | hsa-miR-7-5p | Her2-receptor positive breast cancer | MNDR-E-MI-68797 |
| MNDR | hsa-miR-7-5p | Breast cancer luminal | MNDR-E-MI-68798 |
| MNDR | hsa-miR-7-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-68799 |
| MNDR | hsa-miR-7-5p | Dermatomyositis | MNDR-E-MI-68800 |
| MNDR | hsa-miR-7-5p | Prostate cancer | MNDR-E-MI-68801 |
| MNDR | hsa-miR-7-5p | Gastric cancer | MNDR-E-MI-68802 |
| MNDR | hsa-miR-7-5p | Alzheimer disease | MNDR-E-MI-68803 |
| MNDR | hsa-miR-7-5p | Intracranial aneurysm | MNDR-E-MI-68804 |
| MNDR | hsa-miR-7-5p | Bladder cancer | MNDR-E-MI-68805 |
| MNDR | hsa-miR-7-5p | Polycystic ovary syndrome | MNDR-E-MI-68806 |
| MNDR | hsa-miR-7-5p | Myotonic dystrophy | MNDR-E-MI-68807 |
| MNDR | hsa-miR-7-5p | Head and neck cancer | MNDR-E-MI-68808 |
| MNDR | hsa-miR-7-5p | Leukemia | MNDR-E-MI-68809 |
| MNDR | hsa-miR-7-5p | Huntington disease | MNDR-E-MI-68810 |
| MNDR | hsa-miR-7-5p | Chorea | MNDR-E-MI-68811 |
| MNDR | hsa-miR-7-5p | Cardiovascular disease | MNDR-E-MI-68812 |
| MNDR | hsa-miR-7-5p | Neurodegenerative diseases | MNDR-E-MI-68813 |
| MNDR | hsa-miR-7-5p | Brain cancer | MNDR-E-MI-68814 |
| MNDR | hsa-miR-7-5p | Lung cancer | MNDR-E-MI-68815 |
| MNDR | hsa-miR-7-5p | Fragile x syndrome | MNDR-E-MI-68816 |
| MNDR | hsa-miR-7-5p | Parkinson disease | MNDR-E-MI-68817 |
| MNDR | hsa-miR-7-5p | Basal-like breast cancer | MNDR-E-MI-68818 |
| MNDR | hsa-miR-7-5p | Neuroendocrine neoplasia | MNDR-E-MI-68819 |
| MNDR | hsa-miR-7-5p | Thyroid cancer | MNDR-E-MI-68820 |
| MNDR | hsa-miR-7-5p | Pancreatic cancer | MNDR-E-MI-68821 |
| MNDR | hsa-miR-7-5p | Malignant melanoma | MNDR-E-MI-68822 |
| MNDR | hsa-miR-7-5p | Rectum adenocarcinoma | MNDR-E-MI-68823 |
| MNDR | hsa-miR-7-5p | Colon cancer | MNDR-E-MI-68824 |
| MNDR | hsa-miR-7-5p | Ischemic attack transient | MNDR-E-MI-68825 |
| MNDR | hsa-miR-7-5p | Colon adenocarcinoma | MNDR-E-MI-68826 |
| MNDR | hsa-miR-7-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-68827 |
| MNDR | hsa-miR-7-5p | Ovarian cancer | MNDR-E-MI-68828 |
| MNDR | hsa-miR-7-5p | Prostate adenocarcinoma | MNDR-E-MI-68829 |
| MNDR | hsa-miR-7-5p | Carcinoma ductal breast | MNDR-E-MI-68830 |
| MNDR | hsa-miR-7-5p | Glioblastoma | MNDR-E-MI-68831 |
| MNDR | hsa-miR-7-5p | Astrocytoma | MNDR-E-MI-68832 |
| MNDR | hsa-miR-7-5p | Glioma | MNDR-E-MI-68833 |
| MNDR | hsa-miR-7-5p | Oligodendroglioma | MNDR-E-MI-68834 |
| MNDR | hsa-miR-7-5p | Schwannoma | MNDR-E-MI-68835 |
| MNDR | hsa-miR-7-5p | Osteosarcoma | MNDR-E-MI-68836 |
| MNDR | hsa-miR-7-5p | Breast carcinoma | MNDR-E-MI-68837 |
| MNDR | hsa-miR-7-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-68838 |
| MNDR | hsa-miR-7-5p | Infarction middle cerebral artery | MNDR-E-MI-68839 |
| MNDR | hsa-miR-7-5p | Meningioma | MNDR-E-MI-68840 |
| MNDR | hsa-miR-7-5p | Uterus cancer | MNDR-E-MI-68841 |
| MNDR | hsa-miR-7-5p | Gastric adenocarcinoma | MNDR-E-MI-68842 |
| MNDR | hsa-miR-7-5p | Pituitary adenoma | MNDR-E-MI-68843 |
| MNDR | hsa-miR-7-5p | Lung squamous cell carcinoma | MNDR-E-MI-68844 |
| MNDR | hsa-miR-7-5p | Carcinoma lung non-small-cell | MNDR-E-MI-68845 |
| MNDR | hsa-miR-7-5p | Lung adenocarcinoma | MNDR-E-MI-68846 |
| MNDR | hsa-miR-7-5p | Adrenocortical cancer | MNDR-E-MI-68847 |
| MNDR | hsa-miR-7-5p | Thyroid carcinoma | MNDR-E-MI-68848 |
| MNDR | hsa-miR-7-5p | Pancreatic adenocarcinoma | MNDR-E-MI-68849 |
| MNDR | hsa-miR-7-5p | Scleroderma | MNDR-E-MI-68850 |
| MNDR | hsa-miR-7-5p | Renal cell carcinoma | MNDR-E-MI-68851 |
| MNDR | hsa-miR-7-5p | Large cell carcinoma | MNDR-E-MI-68852 |
| MNDR | hsa-miR-7-5p | Cholangiocarcinoma | MNDR-E-MI-68853 |
| MNDR | hsa-miR-7-5p | Esophageal cancer | MNDR-E-MI-68854 |
| MNDR | hsa-miR-7-5p | Lung small cell carcinoma | MNDR-E-MI-68855 |
| MNDR | hsa-miR-7-5p | Schizophrenia | MNDR-E-MI-68856 |
| MNDR | hsa-miR-7-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-68857 |
| MNDR | hsa-miR-7-5p | T acute lymphoblastic leukemia | MNDR-E-MI-68858 |
| MNDR | hsa-miR-7-5p | Breast invasive carcinoma | MNDR-E-MI-68859 |
| MNDR | hsa-miR-7-5p | Hepatocellular carcinoma | MNDR-E-MI-68860 |
| MNDR | hsa-miR-7-5p | T-cell leukemia | MNDR-E-MI-68861 |
| MNDR | hsa-miR-7-5p | Neuroblastoma | MNDR-E-MI-68862 |
| MNDR | hsa-miR-7-5p | Hodgkin lymphoma | MNDR-E-MI-68863 |
| MNDR | hsa-miR-7-5p | Burkitt lymphoma | MNDR-E-MI-68864 |
| MNDR | hsa-miR-7-5p | Mouth neoplasms | MNDR-E-MI-68865 |
| MNDR | hsa-miR-7-5p | Tonsil cancer | MNDR-E-MI-68866 |
| MNDR | hsa-miR-7-5p | Colorectal cancer | MNDR-E-MI-68867 |
| MNDR | hsa-miR-7-5p | Multiple myeloma | MNDR-E-MI-68868 |
| MNDR | hsa-miR-7-5p | Acute lymphocytic leukemia | MNDR-E-MI-68869 |
| MNDR | hsa-miR-7-5p | Ovarian epithelial cancer | MNDR-E-MI-68870 |
| MNDR | hsa-miR-7-5p | Thyroid cancer papillary | MNDR-E-MI-68871 |
| MNDR | hsa-miR-7-5p | Uterine cervical neoplasms | MNDR-E-MI-68872 |
| MNDR | hsa-miR-7-5p | Ependymoma | MNDR-E-MI-68873 |
| MNDR | hsa-miR-7-5p | Prostatic neoplasms | MNDR-E-MI-68874 |
| MNDR | hsa-miR-7-5p | Aids dementia complex | MNDR-E-MI-68875 |
| MNDR | hsa-miR-7-5p | Epstein-barr virus infections | MNDR-E-MI-68876 |
| MNDR | hsa-miR-7-5p | Mptp poisoning | MNDR-E-MI-68877 |
| MNDR | hsa-miR-7-5p | Pancreatitis chronic | MNDR-E-MI-68878 |
| MNDR | hsa-miR-7-5p | Stroke lacunar | MNDR-E-MI-68879 |
| MNDR | hsa-miR-7-5p | Breast cancer her3+ negative | MNDR-E-MI-68880 |
| MNDR | hsa-miR-7-5p | Duke C | MNDR-E-MI-68881 |
| MNDR | hsa-miR-7-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-68882 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC1 | Homo sapiens | RR00023331 |
TOP